General Information of the m6A Target Gene (ID: M6ATAR00690)
Target Name Death-associated protein kinase 3 (DAPK3)
Synonyms
DAP kinase 3; DAP-like kinase; Dlk; MYPT1 kinase; Zipper-interacting protein kinase; ZIP-kinase
    Click to Show/Hide
Gene Name DAPK3
Chromosomal Location 19p13.3
Family Protein kinase superfamily, CAMK Ser/Thr protein kinase family, DAP kinase subfamily
Function
Serine/threonine kinase which is involved in the regulation of apoptosis, autophagy, transcription, translation and actin cytoskeleton reorganization. Involved in the regulation of smooth muscle contraction. Regulates both type I (caspase-dependent) apoptotic and type II (caspase-independent) autophagic cell deaths signal, depending on the cellular setting. Involved in regulation of starvation-induced autophagy. Regulates myosin phosphorylation in both smooth muscle and non-muscle cells. In smooth muscle, regulates myosin either directly by phosphorylating MYL12B and MYL9 or through inhibition of smooth muscle myosin phosphatase (SMPP1M) via phosphorylation of PPP1R12A; the inhibition of SMPP1M functions to enhance muscle responsiveness to Ca(2+) and promote a contractile state. Phosphorylates MYL12B in non-muscle cells leading to reorganization of actin cytoskeleton. Isoform 2 can phosphorylate myosin, PPP1R12A and MYL12B. Overexpression leads to condensation of actin stress fibers into thick bundles. Involved in actin filament focal adhesion dynamics. The function in both reorganization of actin cytoskeleton and focal adhesion dissolution is modulated by RhoD. Positively regulates canonical Wnt/beta-catenin signaling through interaction with NLK and TCF7L2. Phosphorylates RPL13A on 'Ser-77' upon interferon-gamma activation which is causing RPL13A release from the ribosome, RPL13A association with the GAIT complex and its subsequent involvement in transcript-selective translation inhibition. Enhances transcription from AR-responsive promoters in a hormone- and kinase-dependent manner. Involved in regulation of cell cycle progression and cell proliferation. May be a tumor suppressor.
    Click to Show/Hide
Gene ID 1613
Uniprot ID
DAPK3_HUMAN
HGNC ID
HGNC:2676
Ensembl Gene ID
ENSG00000167657
KEGG ID
hsa:1613
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
DAPK3 can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Protein virilizer homolog (VIRMA) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by VIRMA
Cell Line Human umbilical vein endothelial cells Homo sapiens
Treatment: siVIRMA HUVECs
Control: siControl HUVECs
GSE167067
Regulation
logFC: 5.95E-01
p-value: 2.81E-02
More Results Click to View More RNA-seq Results
In total 1 item(s) under this regulator
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene [1]
Response Summary High expression of KIAA1429 was testified in patients with non-small cell lung cancer and predicted worse prognosis in patients. KIAA1429-guided m6A modifications promoted NSCLC progression via m6A-dependent degradation of Death-associated protein kinase 3 (DAPK3) mRNA.
Target Regulation Down regulation
Responsed Disease Non-small-cell lung carcinoma ICD-11: 2C25.Y
In-vitro Model PC-9 Lung adenocarcinoma Homo sapiens CVCL_B260
NCI-H520 Lung squamous cell carcinoma Homo sapiens CVCL_1566
A-549 Lung adenocarcinoma Homo sapiens CVCL_0023
Lung cancer [ICD-11: 2C25]
In total 1 item(s) under this disease
Experiment 1 Reporting the m6A-centered Disease Response [1]
Response Summary High expression of KIAA1429 was testified in patients with non-small cell lung cancer and predicted worse prognosis in patients. KIAA1429-guided m6A modifications promoted NSCLC progression via m6A-dependent degradation of Death-associated protein kinase 3 (DAPK3) mRNA.
Responsed Disease Non-small-cell lung carcinoma [ICD-11: 2C25.Y]
Target Regulator Protein virilizer homolog (VIRMA) WRITER
Target Regulation Down regulation
In-vitro Model PC-9 Lung adenocarcinoma Homo sapiens CVCL_B260
NCI-H520 Lung squamous cell carcinoma Homo sapiens CVCL_1566
A-549 Lung adenocarcinoma Homo sapiens CVCL_0023
References
Ref 1 VIRMA contributes to non-small cell lung cancer progression via N(6)-methyladenosine-dependent DAPK3 post-transcriptional modification. Cancer Lett. 2021 Dec 1;522:142-154. doi: 10.1016/j.canlet.2021.08.027. Epub 2021 Sep 11.